Sorrento Therapeutics Inc (SRNE)
0.015
0.00 (0.00%)
USD |
OTCM |
Apr 23, 15:52
Sorrento Therapeutics Cash from Operations (TTM): -234.63M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -234.63M |
| March 31, 2023 | -259.96M |
| December 31, 2022 | -293.86M |
| September 30, 2022 | -297.66M |
| June 30, 2022 | -319.60M |
| March 31, 2022 | -317.12M |
| December 31, 2021 | -281.82M |
| September 30, 2021 | -250.55M |
| June 30, 2021 | -210.03M |
| March 31, 2021 | -169.04M |
| December 31, 2020 | -159.54M |
| September 30, 2020 | -154.69M |
| June 30, 2020 | -157.93M |
| March 31, 2020 | -167.24M |
| December 31, 2019 | -173.00M |
| September 30, 2019 | -181.95M |
| June 30, 2019 | -156.82M |
| March 31, 2019 | -132.11M |
| December 31, 2018 | -111.77M |
| September 30, 2018 | -111.64M |
| June 30, 2018 | -103.60M |
| March 31, 2018 | -101.23M |
| December 31, 2017 | -99.18M |
| September 30, 2017 | -70.84M |
| June 30, 2017 | -80.23M |
| Date | Value |
|---|---|
| March 31, 2017 | -72.66M |
| December 31, 2016 | -70.93M |
| September 30, 2016 | -70.57M |
| June 30, 2016 | -66.88M |
| March 31, 2016 | -53.41M |
| December 31, 2015 | -42.07M |
| September 30, 2015 | -33.56M |
| June 30, 2015 | -20.80M |
| March 31, 2015 | -28.49M |
| December 31, 2014 | -28.76M |
| September 30, 2014 | -28.32M |
| June 30, 2014 | -25.70M |
| March 31, 2014 | -23.13M |
| December 31, 2013 | -16.49M |
| September 30, 2013 | -10.61M |
| June 30, 2013 | -8.625M |
| March 31, 2013 | -5.481M |
| December 31, 2012 | -3.797M |
| September 30, 2012 | -3.007M |
| June 30, 2012 | -2.598M |
| March 31, 2012 | -3.113M |
| December 31, 2011 | -2.743M |
| September 30, 2011 | -2.333M |
| June 30, 2011 | -1.955M |
| March 31, 2011 | -1.266M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-319.60M
Minimum
Jun 2022
-154.69M
Maximum
Sep 2020
-222.67M
Average
-210.03M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| Scilex Holding Co | -20.71M |
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Armata Pharmaceuticals Inc | -47.42M |